14 results match your criteria: "Eye Protection Foundation Bayrampasa Eye Hospital[Affiliation]"

Intermediate uveitis is a relatively common form of intraocular inflammation that can be seen at any age. The vitreous is the primary site of inflammation; and the presence of snowballs or snowbank defines its subtype, pars planitis. Since it is a clinical diagnosis, it is important to recognize the typical clinical features and associated ocular complications.

View Article and Find Full Text PDF

Sarcoid Uveitis.

Ocul Immunol Inflamm

February 2024

The Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

View Article and Find Full Text PDF

Editorial 2024.

Ocul Immunol Inflamm

January 2024

The Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

View Article and Find Full Text PDF

Ocular Syphilis.

Ocul Immunol Inflamm

September 2023

The Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.

View Article and Find Full Text PDF

An Overview of Pediatric Uveitis.

Turk Arch Pediatr

July 2023

Eye Protection Foundation Bayrampaşa Eye Hospital, İstanbul, Turkey;Department of Ophthalmology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Turkey.

Article Synopsis
  • * The most common type is anterior uveitis, often linked to juvenile idiopathic arthritis, but intermediate uveitis and other forms can also occur.
  • * Close monitoring is crucial to prevent serious issues like cataracts and high intraocular pressure, with treatments including methotrexate and adalimumab, requiring a collaborative approach for effective management.
View Article and Find Full Text PDF

Developments in uveitis.

Saudi J Ophthalmol

December 2022

Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.

View Article and Find Full Text PDF

Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?

Clin Immunol

January 2023

Joint Rheumatology Program and First Department of Propaedeutic and Internal Medicine, National & Kapodistrian University of Athens Medical School, Athens, Greece. Electronic address:

During the last decades the efficacy of biologic agents, mainly of anti-TNFs, in controlling the activity of serious manifestations of Behcet's Disease (BD) has been established. On the other hand, the clinical heterogeneity of BD has precluded the validation of a widely-accepted composite index for disease assessment and for target disease-state definitions, such as low disease activity and remission, and the testing of their implementation in clinical practice. Therefore, in contrast to other systemic rheumatic diseases, a treat-to-target strategy has not yet been developed in BD.

View Article and Find Full Text PDF

Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT) are relatively new clinical entities characterized by acute pigment dispersion from the iris stroma or iris pigment epithelium, respectively. While BADI presents with diffuse or geographic areas of iris stromal depigmentation without transillumination, BAIT cases typically develop diffuse iris transillumination and mydriatic atonic pupils. Prolonged pigment dispersion and ocular hypertension are more common in BAIT.

View Article and Find Full Text PDF